Background and Significance: Lower limb lymphedema (LLL) induced by standard surgical and radiation treatment for gynecological cancers is a serious complication that can lead to adverse physical and mental patient outcomes1. It is estimated that between 7 and 78 percent of patients treated for gynecological cancers develop LLL after beginning their medical treatment regimen2,3,4. This substantial disparity is likely due to variable definitions of lymphedema, bias regarding how lymphedema is